Erika Fry

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive supercomputer will give it the edge to dominate the sector.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

We recognize some of the most staggering, game-changing, life-improving developments of the year.

The vitriol following the killing of UHC CEO Brian Thompson exposed Americans' rage about their health care system. How justified is that rage?

Tirzepatide, a drug for diabetes and obesity, has sent the 148-year-old pharma giant on a wild ride. It’s now the ninth most valuable company in the world.

Delayed prescriptions, missed payments, and bags of cash: How the hack of a UnitedHealth Group unit exposed the flaws in the health care landscape.

The research community has a lot to lose in the debate over whether the long-tailed macaque should be declared off-limits for labs.

The industry’s favorite lab monkey was already in short supply. Then the arrest of a Cambodian wildlife official made the situation a lot worse.

In a world of fast-advancing technology and precision medicine, are our primate relatives really the best tool for developing and testing human medicines?

I was working on a feature story about a crisis in America’s lab monkey supply chain when was thrust into a medical drama myself.

Research from the Kaiser Family Foundation shows that Black, Hispanic, and Asian adults with mental health problems are less likely to receive treatment than their white counterparts.

Loneliness and isolation have been linked to early death and serious health problems for the elderly. Robots could help solve the problem.

“If you think that you do not have anyone in recovery or with substance-use [issues] in your business, you’re either too small, or you’re mistaken.”

From amplifying employee voices to leading from the top, these are the best practices for a recovery-friendly culture.

For the one in six Americans with substance-use disorder, “recovery-friendly” policies at work can make all the difference.

As big healthcare gets bigger, CEO Sarah London sees a narrower, more focused path for the Medicaid and Medicare insurer Centene.

The journey of the Jada System is a parable of the business of women’s health care.

Alto Pharmacy is growing fast by fighting ‘non-adherence.’

The ESG label has taken on toxic overtones in politics. But companies increasingly see sustainability as a financially prudent strategy.

PE firms have become major investors in the space, and some therapists say it’s hurting the quality of care.